NASDAQ (USD): Bionomics Limited (BNOX)
Last Price
0.63
Today's Change
+0.043 (7.32%)
Day's Change
0.58 - 0.63
Trading Volume
84,652
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Bitcoin ETFs Bleed US$1.2b in Longest Run of Net Outflows
2
Risk-on Momentum in Stocks Succumbs to Mounting Growth Worries
3
Morgan Stanley Cuts Oil Forecast Again as Concerns Deepen
4
Tropical Storm Francine Disrupts Gulf Coast Oil, Gas Output
5
KenTrade by Kenanga Webinar
[KenTrade Webinar] Telco Sector Outlook: Potential Opportunities from Recent Trends
#
Stock
Score
BKYI
BIO-key International, Inc.
AILE
Arrowroot Acquisition Corp.
500
AGN
BABA
Alibaba Group Holding Limited
AAPL
Apple Inc.
400
6
MELI
MercadoLibre, Inc.
375
7
PLTR
Palantir Technologies Inc.
350
8
FB
275
9
ETN
Eaton Corporation plc
250
10
IDTI
Last
Change
Volume
NVDA
115.70
+7.60
356,106,443
CNEY
1.30
+1.02
308,052,284
FTCI
0.481
+0.256
271,207,641
SQQQ
8.65
-0.47
237,938,456
TANH
0.173
+0.034
209,968,617
BCTX
0.653
+0.033
162,759,929
SOXL
31.54
+3.19
121,423,610
LMDX
0.016
-0.018
120,553,903
QH
1.76
+0.439
111,520,746
MULN
0.175
108,821,740
ASML
793.27
+41.89
1,779,635
MPWR
884.29
+36.59
283,138
KLAC
744.65
+31.19
429,526
FSLR
236.56
+28.34
4,491,508
SMCI
440.91
+28.19
6,401,188
2,045.70
+28.12
178,961
LRCX
757.63
+26.07
1,267,622
FNGU
366.30
+21.88
994,533
FICO
1,816.00
+18.72
82,060
LLY
918.05
+16.80
1,713,652
BRK-A
678,399.60
-9,676.375
2,058
1,629.32
-188.66
1,851,535
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
838.63
-96.05
902,546
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
NVR
9,040.00
-72.89
12,099
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....